Literature DB >> 10954675

Topical imiquimod treatment of a cutaneous melanoma metastasis.

A Steinmann, J O Funk, G Schuler, P von den Driesch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10954675

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  22 in total

1.  Clinical effects of in situ photoimmunotherapy on late-stage melanoma patients: a preliminary study.

Authors:  Xiaosong Li; Mark F Naylor; Henry Le; Robert E Nordquist; T Kent Teague; C Anthony Howard; Cynthia Murray; Wei R Chen
Journal:  Cancer Biol Ther       Date:  2010-12-01       Impact factor: 4.742

2.  Additive melanoma suppression with intralesional phospholipid-conjugated TLR7 agonists and systemic IL-2.

Authors:  Tomoko Hayashi; Michael Chan; John T Norton; Christina C N Wu; Shiyin Yao; Howard B Cottam; Rommel I Tawatao; Maripat Corr; Dennis A Carson; Gregory A Daniels
Journal:  Melanoma Res       Date:  2011-02       Impact factor: 3.599

Review 3.  The role of topical immune response modifiers in skin cancer.

Authors:  Courtney Woodmansee; Jessica Pillow; Robert B Skinner
Journal:  Drugs       Date:  2006       Impact factor: 9.546

4.  Imiquimod inhibits melanoma development by promoting pDC cytotoxic functions and impeding tumor vascularization.

Authors:  Caroline Aspord; Laetitia Tramcourt; Claire Leloup; Jean-Paul Molens; Marie-Therese Leccia; Julie Charles; Joel Plumas
Journal:  J Invest Dermatol       Date:  2014-04-21       Impact factor: 8.551

Review 5.  Subcutaneous metastases from melanoma: a discussion of clinical experience.

Authors:  Piotr Rutkowski; Marcin Zdzienicki; Katarzyna Kozak
Journal:  Melanoma Manag       Date:  2014-09-05

6.  Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil.

Authors:  Valerie Florin; Eve Desmedt; Sophie Vercambre-Darras; Laurent Mortier
Journal:  Invest New Drugs       Date:  2011-07-13       Impact factor: 3.850

7.  Toll-like receptors and cutaneous melanoma.

Authors:  Ilaria Coati; Serena Miotto; Irene Zanetti; Mauro Alaibac
Journal:  Oncol Lett       Date:  2016-09-21       Impact factor: 2.967

8.  Effectiveness of imiquimod limited to dermal melanoma metastases, with simultaneous resistance of subcutaneous metastasis.

Authors:  Kristin Turza; Lynn T Dengel; Rebecca C Harris; James W Patterson; Kevin White; William W Grosh; Craig L Slingluff
Journal:  J Cutan Pathol       Date:  2009-07-07       Impact factor: 1.587

9.  Toll-like receptors: role in dermatological disease.

Authors:  Aswin Hari; Tracy L Flach; Yan Shi; P Régine Mydlarski
Journal:  Mediators Inflamm       Date:  2010-08-22       Impact factor: 4.711

10.  Effective topical treatment of subcutaneous murine B16F10-Nex2 melanoma by the antimicrobial peptide gomesin.

Authors:  Elaine G Rodrigues; Andrey Ss Dobroff; Clarissa F Cavarsan; Thaysa Paschoalin; Leonardo Nimrichter; Renato A Mortara; Edson Lucas Santos; Marcos A Fázio; Antonio Miranda; Sirlei Daffre; Luiz R Travassos
Journal:  Neoplasia       Date:  2008-01       Impact factor: 5.715
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.